News archive for 2020

methamphetamine

Emerging methamphetamine industry in Afghanistan ‘worrying’, says new EMCDDA study

24.11.2020

There are signs that a methamphetamine industry is taking hold in Afghanistan, according to a new report published today by the EU drugs agency (EMCDDA).

Fifty countries gather for 2020 virtual Reitox week

23.11.2020

Representatives of candidate, potential candidate and neighbouring countries of the EU are joining members of the EMCDDA’s Reitox network this week (23–27 November) for the agency’s ninth Reitox week.
EMCDDA building

EMCDDA Scientific Committee appoints new Chair and Vice-Chair

20.11.2020

The EMCDDA Scientific Committee has elected its new Chair and Vice-Chair for the period 2020–22. Prof. Dr. Catherine Comiskey (Ireland) was elected to the position of Chair and Prof. Dr. Henri...

New ESPAD results: teenage drinking and smoking down, but concerns over risky cannabis use and new addictive behaviours

12.11.2020

Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there are concerns over potentially risky cannabis use and the challenges posed by new addictive behaviours...
25 year of drug monitoring (1995-2020)

Looking back on 25 years of monitoring prevention in Europe

30.10.2020

By Gregor Burkhart, Principal scientific analyst — prevention, EMCDDA

Upcoming data on substance use and risk behaviours among school students across Europe

23.10.2020

The latest European data and analysis on substance use and risk behaviours among 15–16-year-old school students will be released in a new report on 12 November. The findings are based on a 2019...
open door

EMCDDA Best practice portal update (3/2020)

20.10.2020

Substitution treatment for stimulants users? Finding a pharmacological treatment for stimulant users has been a research priority for the last decade. Many classes of drugs have been tested:...

Registration opens for European Drugs Winter and Summer Schools 2021

19.10.2020

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are pleased to open registration today for two upcoming joint events in 2021: the European Drugs Winter School (EDWS) and the European...
EU4MD networking photo

News from EU4Monitoring Drugs, an EMCDDA technical cooperation project

01.10.2020

This content was published in the EU4MD update released on 01.10.2020. This update also presents a section on studies, upcoming events, and a research corner.
25 year of drug monitoring (1995-2020)

Looking back on 25 years of annual reporting on the drugs problem in Europe

30.09.2020

This month, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe. The journey begins with the first report describing the drug...

EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the eastern ENP region

28.09.2020

The expansion of contactless drug dealing, the increase in the use of licit drugs and the adaptation of drug treatment protocols during lockdown are among the findings highlighted today in a new...

EMCDDA and Kosovo seal new agreement in Pristina

28.09.2020

The EMCDDA and Kosovo* are signing a new Working Arrangement today which will pave the way for greater cooperation on monitoring the drug phenomenon in Europe and beyond its borders. Dignitaries...
Launch of the 2020 European Drug Report: presentation by EMCDDA Director Alexis Goosdeel

Speech by Alexis Goosdeel: European Drug Report 2020: Trends and Developments — Key findings

22.09.2020

Occasion: Virtual event, European Drug Report 2020: Trends and Developments — Key findings Introduction Good morning, It is my pleasure to present to you the new report on the drug situation in...
EDR covers

COVID-19 disruption and a strong drug market bring new threats to health and security in Europe

22.09.2020

High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report...
EDR covers

Save the date: European Drug Report 2020 to be released on 22 September

08.09.2020

How is the COVID-19 pandemic affecting drug use, supply and services? What are the health costs of drug use in Europe today? What do the latest data tell us about drug production and trafficking...

Facts and myths about overdose and take-home naloxone — EMCDDA publishes new resources

31.08.2020

Over the past five years, more than 40 000 people have died of a drug-related overdose in the European Union and the UK; around 80% of these being linked to the use of heroin or other opioids. Yet,...
hepatitis virus

World Hepatitis Day: EMCDDA showcases hepatitis questionnaire for drug service staff to refresh knowledge and identify training needs

28.07.2020

Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes. It is...

Stronger together: EU agencies join forces to respond to COVID-19

14.07.2020

Since the start of the COVID-19 pandemic, the nine JHA agencies (CEPOL, EASO, EIGE, EMCDDA, eu-LISA, Eurojust, Europol, FRA and Frontex) have been supporting the EU Member States and institutions in...

EMCDDA welcomes external partners to virtual event on lessons learned from the impact of COVID-19 on the drug situation in Europe

30.06.2020

The EMCDDA will be joined by a range of its external partners today in a virtual event following on from International day against drug abuse and illicit trafficking (26 June). The meeting is a...
microphone

Speech by Alexis Goosdeel: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective

26.06.2020

Occasion: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective Thank you Chairperson and colleagues,

EMCDDA and Europol join EU institutions in dialogue on the impact of COVID-19 on the world drug situation

26.06.2020

On the occasion of International day against drug abuse and illicit trafficking, the EMCDDA and Europol are joining representatives of the EU institutions today in providing the European perspective...
photo alexis goosdeel

EMCDDA Management Board renews mandate of Alexis Goosdeel

25.06.2020

The EMCDDA Management Board took the unanimous decision today to renew the mandate of the agency’s Director, Alexis Goosdeel, for the next five years. Mr Goosdeel took up the post of EMCDDA Director...
Computer-generated simulation of a corona virus (copyrighted)

COVID-19: New EMCDDA study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression

23.06.2020

A decline in stimulant drug use but some rises in the consumption of cannabis and licit substances are among the findings presented today in a new EMCDDA report The impact of COVID-19 on patterns of...
Paper showing years with 2019 pinned

A year in review: General Report of Activities 2019 published

15.06.2020

New products and services, working in partnership, and support to policy and practice in the fields of health and security are among the features presented in the latest EMCDDA General Report of...
Alexis Goosdeel, EMCDDA Director

Impact of COVID-19 on the drug situation in Europe — EMCDDA Director presents findings to European Parliament

04.06.2020

Today, EMCDDA Director Alexis Goosdeel presented to the European Parliament the agency’s recent research findings on the impact of COVID-19 on the drug phenomenon in Europe.

New report provides window onto EU drug market changes during COVID-19

29.05.2020

What effect is COVID-19 having on the largest criminal market in the EU? This question is explored in EU Drug Markets: Impact of COVID-19, a new report out today from the EU drugs agency (EMCDDA) and...

New Zealand: referendum on cannabis legalisation to take place in September 2020

28.05.2020

Following an agreement made in 2017 between the ruling coalition parties in New Zealand, it has been announced that a referendum on legalising the recreational use of cannabis will be held together...
computer simulation of a Hep C virus

Testing for drug-related infectious diseases — a crucial step towards meeting international health goals

20.05.2020

Testing for drug-related infectious diseases among people who inject drugs (PWID) is crucial if international health targets are to be met. This is among the conclusions of a new EMCDDA report out...

COVID-19: New EMCDDA study highlights drop in availability of drug services in Europe but increase in innovation

12.05.2020

As Europe grapples with the unprecedented public health threat posed by COVID-19, how is the outbreak affecting drug users and service providers? In a new study published today — Impact of COVID-19...
depiction of circuit board

Increase in darknet market activity for cannabis as users stock up for lockdown

05.05.2020

The COVID-19 pandemic has profoundly impacted on our daily lives, including our behaviour as consumers. Just as we have seen online shopping for other goods increase during lockdowns, will we see a...
Loading